{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T03:28:39Z","timestamp":1790652519391,"version":"4.1.0"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T00:00:00Z","timestamp":1578355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.cellsig.2020.109526","type":"journal-article","created":{"date-parts":[[2020,1,10]],"date-time":"2020-01-10T00:54:21Z","timestamp":1578617661000},"page":"109526","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Glycosphingolipid metabolism and polycystic kidney disease"],"prefix":"10.1016","volume":"69","author":[{"given":"Thomas A.","family":"Natoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Modur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oxana","family":"Ibraghimov-Beskrovnaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cellsig.2020.109526_bb0005","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0140-6736(18)32782-X","article-title":"Autosomal dominant polycystic kidney disease","volume":"393","author":"Cornec-Le Gall","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.cellsig.2020.109526_bb0010","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-018-0047-y","article-title":"Polycystic kidney disease","volume":"4","author":"Bergmann","year":"2018","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.cellsig.2020.109526_bb0015","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1152\/physiol.00032.2014","article-title":"Molecular pathways and therapies in autosomal-dominant polycystic kidney disease","volume":"30","author":"Saigusa","year":"2015","journal-title":"Physiology"},{"key":"10.1016\/j.cellsig.2020.109526_bb0020","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.semnephrol.2018.01.007","article-title":"Targeting Glucosylceramide synthesis in the treatment of rare and common renal disease","volume":"38","author":"Shayman","year":"2018","journal-title":"Semin. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109526_bb0025","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nm.2171","article-title":"Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse models","volume":"16","author":"Natoli","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellsig.2020.109526_bb0030","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.1007\/s00018-007-7076-0","article-title":"The metabolism and function of sphingolipids and glycosphingolipids","volume":"64","author":"Lahiri","year":"2007","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cellsig.2020.109526_bb0035","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1021\/cr2002917","article-title":"Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics","volume":"111","author":"Merrill","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.cellsig.2020.109526_bb0040","first-page":"1","article-title":"An overview of sphingolipid metabolism: from synthesis to breakdown","author":"Gault","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.cellsig.2020.109526_bb0045","doi-asserted-by":"crossref","first-page":"8848","DOI":"10.1002\/anie.200902620","article-title":"Glycosphingolipids - nature, function, and pharmacological modulation","volume":"48","author":"Wennekes","year":"2009","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.cellsig.2020.109526_bb0050","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.canlet.2003.08.034","article-title":"Ceramide synthesis and metabolism as a target for cancer therapy","volume":"206","author":"Reynolds","year":"2004","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cellsig.2020.109526_bb0055","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/nchembio.392","article-title":"An update on sphingosine-1-phosphate and other sphingolipid mediators","volume":"6","author":"Fyrst","year":"2010","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.cellsig.2020.109526_bb0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1046\/j.1523-1755.2000.00136.x","article-title":"Sphingolipids","volume":"58","author":"Shayman","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2020.109526_bb0065","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-1-4419-6741-1_10","article-title":"Extracellular and intracellular actions of sphingosine-1-phosphate","author":"Strub","year":"2010","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.cellsig.2020.109526_bb0070","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00418-016-1518-4","article-title":"Lipid glycosylation: a primer for histochemists and cell biologists","volume":"147","author":"Kopitz","year":"2017","journal-title":"Histochem. Cell Biol."},{"key":"10.1016\/j.cellsig.2020.109526_bb0075","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.219204","article-title":"Glycosphingolipid metabolism in cell fate specification","volume":"131","author":"Russo","year":"2018","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.cellsig.2020.109526_bb0080","doi-asserted-by":"crossref","first-page":"4893","DOI":"10.1021\/bi002836k","article-title":"Enzymes of sphingolipid metabolism: from modular to integrative signaling","volume":"40","author":"Hannun","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.cellsig.2020.109526_bb0085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/ncb0107-7","article-title":"Lipid rafts: at a crossroad between cell biology and physics","volume":"9","author":"Jacobson","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cellsig.2020.109526_bb0090","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/mrd.22848","article-title":"Ganglioside GM3 induces cumulus cell apoptosis through inhibition of epidermal growth factor receptor-mediated PI3K\/AKT signaling pathways during in vitro maturation of pig oocytes","volume":"84","author":"Park","year":"2017","journal-title":"Mol. Reprod. Dev."},{"key":"10.1016\/j.cellsig.2020.109526_bb0095","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/S0022-2275(20)39163-X","article-title":"Role of lactosylceramide and MAP kinase in the proliferation of proximal tubular cells in human polycystic kidney disease","volume":"37","author":"Chatterjee","year":"1996","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cellsig.2020.109526_bb0100","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/S0022-2275(20)41159-9","article-title":"Abnormalities of glycosphingolipid, sulfatide, and ceramide in the polycystic (cpk\/cpk) mouse","volume":"35","author":"Deshmukh","year":"1994","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cellsig.2020.109526_bb0105","article-title":"Differences in the timing and magnitude of Pkd1 gene deletion determine the severity of polycystic kidney disease in an orthologous mouse model of ADPKD","volume":"4","author":"Rogers","year":"2016","journal-title":"Phys. Rep."},{"key":"10.1016\/j.cellsig.2020.109526_bb0110","doi-asserted-by":"crossref","first-page":"6233","DOI":"10.1021\/ac400931u","volume":"85","author":"Ruh","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1016\/j.cellsig.2020.109526_bb0115","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1194\/jlr.M040014","article-title":"MALDI imaging MS reveals candidate lipid markers of polycystic kidney disease","volume":"54","author":"Ruh","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cellsig.2020.109526_bb0120","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.plipres.2015.11.001","article-title":"Unraveling the role of the target of Rapamycin signaling in sphingolipid metabolism","volume":"61","author":"Teixeira","year":"2016","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.cellsig.2020.109526_bb0125","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.tcb.2015.10.003","article-title":"TOR complexes and the maintenance of cellular homeostasis","volume":"26","author":"Eltschinger","year":"2016","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.cellsig.2020.109526_bb0130","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.molmed.2011.06.003","article-title":"MTOR signaling in polycystic kidney disease","volume":"17","author":"Ibraghimov-Beskrovnaya","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.cellsig.2020.109526_bb0135","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1038\/onc.2012.567","article-title":"The evolution of the TOR pathway and its role in cancer","volume":"32","author":"Beauchamp","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.cellsig.2020.109526_bb0140","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1194\/jlr.R800003-JLR200","article-title":"New insights into sphingolipid metabolism and function in budding yeast","volume":"49","author":"Dickson","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cellsig.2020.109526_bb0145","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cmet.2007.11.015","article-title":"Regulation of Ceramide biosynthesis by TOR complex 2","volume":"7","author":"Aronova","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.cellsig.2020.109526_bb0150","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/ncb2480","article-title":"Plasma membrane stress induces relocalization of Slm proteins and activation of TORC2 to promote sphingolipid synthesis","volume":"14","author":"Berchtold","year":"2012","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cellsig.2020.109526_bb0155","doi-asserted-by":"crossref","first-page":"19222","DOI":"10.1073\/pnas.1116948108","article-title":"Protein kinase Ypk1 phosphorylates regulatory proteins Orm1 and Orm2 to control sphingolipid homeostasis in Saccharomyces cerevisiae","volume":"108","author":"Roelants","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cellsig.2020.109526_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.cub.2017.11.069","article-title":"Cell size and growth rate are modulated by TORC2-dependent signals","volume":"28","author":"Lucena","year":"2018","journal-title":"Curr. Biol."},{"key":"10.1016\/j.cellsig.2020.109526_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2017.11.011","article-title":"mTORC2 promotes tumorigenesis via lipid synthesis","volume":"32","author":"Guri","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.cellsig.2020.109526_bb0170","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1681\/ASN.2009121302","article-title":"Sirolimus therapy to halt the progression of ADPKD","volume":"21","author":"Perico","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109526_bb0175","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease","volume":"363","author":"Serra","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2020.109526_bb0180","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in patients with autosomal dominant polycystic kidney disease","volume":"363","author":"Walz","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.cellsig.2020.109526_bb0185","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/j.1600-6143.2010.03152.x","article-title":"Therapeutic mTOR inhibition in autosomal dominant polycystic kidney disease: what is the appropriate serum level?","volume":"10","author":"Canaud","year":"2010","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.cellsig.2020.109526_bb0190","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/2211-5463.12039","article-title":"mTOR inhibition by rapamycin increases ceramide synthesis by promoting transforming growth factor-\u03b21\/Smad signaling in the skin","volume":"6","author":"Yamane","year":"2016","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.cellsig.2020.109526_bb0195","doi-asserted-by":"crossref","first-page":"E986","DOI":"10.1210\/jc.2015-1288","article-title":"Aberrant TGF\u03b2 signalling contributes to dysregulation of sphingolipid metabolism in intrauterine growth restriction","volume":"100","author":"Chauvin","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.cellsig.2020.109526_bb0200","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1152\/physiolgenomics.00176.2011","article-title":"EGFR regulation of epidermal barrier function","volume":"44","author":"Tran","year":"2012","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.cellsig.2020.109526_bb0205","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/j.1460-2075.1995.tb07099.x","article-title":"Tumor necrosis factor (TNF)-\u03b1 activates c-raf-1 kinase via the p55 TNF receptor engaging neutral sphingomyelinase","volume":"14","author":"Belka","year":"1995","journal-title":"EMBO J."},{"key":"10.1016\/j.cellsig.2020.109526_bb0210","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jbior.2014.10.002","article-title":"Roles and regulation of neutral sphingomyelinase-2 in cellular and pathological processes","author":"Shamseddine","year":"2015","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.cellsig.2020.109526_bb0215","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1081\/IMM-120037928","article-title":"Expression of neutral glycosphingolipids in the brain and spleen of mice lacking TNF receptor 1","volume":"33","author":"Markoti\u0107","year":"2004","journal-title":"Immunol. Investig."},{"key":"10.1016\/j.cellsig.2020.109526_bb0220","doi-asserted-by":"crossref","first-page":"F221","DOI":"10.1152\/ajprenal.00104.2019","article-title":"Interleukin-1 receptor activation aggravates autosomal dominant polycystic kidney disease by modulating regulated necrosis","volume":"317","author":"Yang","year":"2019","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.cellsig.2020.109526_bb0225","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1172\/JCI80467","article-title":"Macrophage migration inhibitory factor promotes cyst growth in polycystic kidney disease","volume":"125","author":"Chen","year":"2015","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cellsig.2020.109526_bb0230","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nm1783","article-title":"A tumor necrosis factor-\u03b1-mediated pathway promoting autosomal dominant polycystic kidney disease","volume":"14","author":"Li","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellsig.2020.109526_bb0235","first-page":"C487","article-title":"Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD","volume":"269","author":"Du","year":"1995","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.cellsig.2020.109526_bb0240","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1093\/hmg\/ddp165","article-title":"Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks","volume":"18","author":"Song","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cellsig.2020.109526_bb0245","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/path.2734","article-title":"Elevated TGF\u03b2-Smad signalling in experimental Pkd1 models and human patients with polycystic kidney disease","volume":"222","author":"Hassane","year":"2010","journal-title":"J. Pathol."},{"key":"10.1016\/j.cellsig.2020.109526_bb0250","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/j.yexcr.2012.03.021","article-title":"Transforming growth factor-\u03b2 inhibits cystogenesis in human autosomal dominant polycystic kidney epithelial cells","volume":"318","author":"Elberg","year":"2012","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.cellsig.2020.109526_bb0255","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00337-17","article-title":"Mitochondrial abnormality facilitates cyst formation in autosomal dominant polycystic kidney disease","volume":"37","author":"Ishimoto","year":"2017","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cellsig.2020.109526_bb0260","doi-asserted-by":"crossref","first-page":"3397","DOI":"10.1093\/hmg\/dds172","article-title":"Loss of GM3 synthase gene, but not sphingosine kinase 1, is protective against murine nephronophthisis-related polycystic kidney disease","volume":"21","author":"Natoli","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cellsig.2020.109526_bb0265","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.ymgme.2018.02.014","article-title":"Fabry disease revisited: management and treatment recommendations for adult patients","volume":"123","author":"Ortiz","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.cellsig.2020.109526_bb0270","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1523-1755.2004.00846.x","article-title":"Parapelvic kidney cysts: a distinguishing feature with high prevalence in Fabry disease","volume":"66","author":"Ries","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2020.109526_bb0275","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00004728-200403000-00002","article-title":"Fabry disease: renal Sonographic and magnetic resonance imaging findings in affected males and carrier females with the classic and cardiac variant phenotypes","volume":"28","author":"Glass","year":"2004","journal-title":"J. Comput. Assist. Tomogr."},{"key":"10.1016\/j.cellsig.2020.109526_bb0280","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/ndt\/gfx009","article-title":"Parapelvic cysts, a distinguishing feature of renal Fabry disease","volume":"33","author":"Pisani","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cellsig.2020.109526_bb0285","doi-asserted-by":"crossref","first-page":"806","DOI":"10.5301\/jn.5000031","article-title":"Simultaneous multicystic kidney and Anderson-Fabry disease: 2 separate entities or same side of the coin","volume":"24","author":"Pisani","year":"2011","journal-title":"J. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109526_bb0290","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/sdi.12605","article-title":"Diagnosis and Management of Acquired Cystic Kidney Disease and Renal Tumors in ESRD patients","volume":"30","author":"Rahbari-Oskoui","year":"2017","journal-title":"Semin. Dial."},{"key":"10.1016\/j.cellsig.2020.109526_bb0295","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1177\/0300985814549210","article-title":"Polycystic kidneys and GM2 Gangliosidosis-like disease in neonatal springboks (Antidorcas marsupialis)","volume":"52","author":"Herder","year":"2015","journal-title":"Vet. Pathol."},{"key":"10.1016\/j.cellsig.2020.109526_bb0300","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/ki.1982.146","article-title":"Polycystic kidney and liver disease in Springbok: I. morphology of the lesions","volume":"22","author":"Iverson","year":"1982","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2020.109526_bb0305","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1638\/2009-0119.1","article-title":"Lysosomal storage disease in two presumed-related springboks (Antidorcas marsupialis)","volume":"41","author":"Laurent","year":"2010","journal-title":"J. Zoo Wildlife Med."},{"key":"10.1016\/j.cellsig.2020.109526_bb0310","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1002\/1873-3468.13114","article-title":"Emerging concepts of ganglioside metabolism","volume":"592","author":"Sandhoff","year":"2018","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cellsig.2020.109526_bb0315","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10863-015-9602-3","article-title":"Sphingolipids and mitochondrial apoptosis","volume":"48","author":"Patwardhan","year":"2016","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.cellsig.2020.109526_bb0320","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/ncb2328","article-title":"Apicobasal domain identities of expanding tubular membranes depend on glycosphingolipid biosynthesis","volume":"13","author":"Zhang","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.cellsig.2020.109526_bb0325","doi-asserted-by":"crossref","first-page":"R421","DOI":"10.1016\/j.cub.2018.03.010","article-title":"How the Ciliary membrane is organized inside-out to communicate outside-in","volume":"28","author":"Garcia","year":"2018","journal-title":"Curr. Biol."},{"key":"10.1016\/j.cellsig.2020.109526_bb0330","doi-asserted-by":"crossref","first-page":"5849","DOI":"10.1021\/acs.chemrev.8b00439","article-title":"Biological membrane organization and cellular Signaling","volume":"119","author":"Cheng","year":"2019","journal-title":"Chem. Rev."},{"key":"10.1016\/j.cellsig.2020.109526_bb0335","doi-asserted-by":"crossref","first-page":"13678","DOI":"10.1073\/pnas.0703650104","article-title":"Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance","volume":"104","author":"Kabayama","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cellsig.2020.109526_bb0340","doi-asserted-by":"crossref","first-page":"48770","DOI":"10.1074\/jbc.M308818200","article-title":"Ganglioside GM3 blocks the activation of epidermal growth factor receptor induced by integrin at specific tyrosine sites","volume":"278","author":"Wang","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2020.109526_bb0345","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11010-013-1720-9","article-title":"Ganglioside GM3 promotes HGF-stimulated motility of murine hepatoma cell through enhanced phosphorylation of cMet at specific tyrosine sites and PI3K\/Akt-mediated migration signaling","volume":"382","author":"Li","year":"2013","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.cellsig.2020.109526_bb0350","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/sj.ki.5002229","article-title":"Hyperproliferation of PKD1 cystic cells is induced by insulin-like growth factor-1 activation of the Ras\/Raf signalling system","volume":"72","author":"Parker","year":"2007","journal-title":"Kidney Int."},{"key":"10.1016\/j.cellsig.2020.109526_bb0355","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1172\/JCI2071","article-title":"Epidermal growth factor receptor activity mediates renal cyst formation in polycystic kidney disease","volume":"101","author":"Richards","year":"1998","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cellsig.2020.109526_bb0360","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1172\/JCI41531","article-title":"Failure to ubiquitinate c-met leads to hyperactivation of mTOR signaling in a mouse model of autosomal dominant polycystic kidney disease","volume":"120","author":"Qin","year":"2010","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cellsig.2020.109526_bb0365","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s10719-016-9684-0","article-title":"Changes of glycoconjugate expression profiles during early development","volume":"34","author":"Handa","year":"2017","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.cellsig.2020.109526_bb0370","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.chemphyslip.2018.08.003","article-title":"Sphingolipids and lipid rafts: novel concepts and methods of analysis","volume":"216","author":"Bieberich","year":"2018","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.cellsig.2020.109526_bb0375","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.chemphyslip.2018.11.006","article-title":"\u201cRafts\u201d: a nickname for putative transient nanodomains","volume":"218","author":"Go\u00f1i","year":"2019","journal-title":"Chem. Phys. Lipids"},{"key":"10.1016\/j.cellsig.2020.109526_bb0380","doi-asserted-by":"crossref","first-page":"6131","DOI":"10.1002\/anie.201700570","article-title":"Characterization of plasma membrane ceramides by super-resolution microscopy","volume":"56","author":"Burgert","year":"2017","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.cellsig.2020.109526_bb0385","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1006\/bbrc.2001.5045","article-title":"Molecular mechanisms of ceramide-mediated CD95 clustering","volume":"284","author":"Grassm\u00e9","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellsig.2020.109526_bb0390","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bbamem.2008.07.030","article-title":"Ceramide-enriched membrane domains-structure and function","volume":"1788","author":"Zhang","year":"2009","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.cellsig.2020.109526_bb0395","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1091\/mbc.e13-12-0730","article-title":"Primary cilia in stem cells and neural progenitors are regulated by neutral sphingomyelinase 2 and ceramide","volume":"25","author":"He","year":"2014","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.cellsig.2020.109526_bb0400","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1194\/jlr.M900097-JLR200","article-title":"Regulation of primary cilia formation by ceramide","volume":"50","author":"Wang","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.cellsig.2020.109526_bb0405","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ydbio.2018.03.007","article-title":"Sending mixed signals: cilia-dependent signaling during development and disease","volume":"447","author":"Elliott","year":"2019","journal-title":"Dev. Biol."},{"key":"10.1016\/j.cellsig.2020.109526_bb0410","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41581-019-0116-9","article-title":"Cellular signalling by primary cilia in development, organ function and disease","volume":"15","author":"Anvarian","year":"2019","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109526_bb0415","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.febslet.2007.03.065","article-title":"GM1 and GM3 gangliosides highlight distinct lipid microdomains within the apical domain of epithelial cells","volume":"581","author":"Janich","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cellsig.2020.109526_bb0420","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1007\/s00018-015-1838-x","article-title":"Protein composition and movements of membrane swellings associated with primary cilia","volume":"72","author":"Mohieldin","year":"2015","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cellsig.2020.109526_bb0425","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s11745-010-3432-1","article-title":"Lipidomic analysis of porcine olfactory epithelial membranes and cilia","volume":"45","author":"Lobasso","year":"2010","journal-title":"Lipids"},{"key":"10.1016\/j.cellsig.2020.109526_bb0430","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1091\/mbc.E15-06-0371","article-title":"Regulation of Chlamydomonas flagella and ependymal cell motile cilia by ceramide-mediated translocation of GSK3","volume":"26","author":"Kong","year":"2015","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.cellsig.2020.109526_bb0435","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/hmg\/ddw093","article-title":"Reduction of ciliary length through pharmacologic or genetic inhibition of CDK5 attenuates polycystic kidney disease in a model of nephronophthisis","volume":"25","author":"Husson","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cellsig.2020.109526_bb0440","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/ng.2715","article-title":"Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease","volume":"45","author":"Ma","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.cellsig.2020.109526_bb0445","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.devcel.2015.08.001","article-title":"Phosphoinositides regulate Ciliary protein trafficking to modulate hedgehog Signaling","volume":"34","author":"Garcia-Gonzalo","year":"2015","journal-title":"Dev. Cell"},{"key":"10.1016\/j.cellsig.2020.109526_bb0450","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.devcel.2015.06.016","article-title":"Modulation of Ciliary Phosphoinositide content regulates trafficking and sonic hedgehog Signaling output","volume":"34","author":"Ch\u00e1vez","year":"2015","journal-title":"Dev. Cell"},{"key":"10.1016\/j.cellsig.2020.109526_bb0455","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.krcp.2014.05.002","article-title":"Cyst growth, polycystins, and primary cilia in autosomal dominant polycystic kidney disease","volume":"33","author":"Lee","year":"2014","journal-title":"Kidney Res. Clin. Pract."},{"key":"10.1016\/j.cellsig.2020.109526_bb0460","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1023\/B:GLYC.0000046274.35732.47","article-title":"Integration of glycosphingolipid metabolism and cell-fate decisions in cancer and stem cells: review and hypothesis","volume":"21","author":"Bieberich","year":"2004","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.cellsig.2020.109526_bb0465","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1074\/jbc.270.6.2859","article-title":"Cell cycle arrest induced by an inhibitor of glucosylceramide synthase: correlation with cyclin-dependent kinases","volume":"270","author":"Rani","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cellsig.2020.109526_bb0470","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.3390\/ijms16035076","article-title":"Ceramide-induced apoptosis in renal tubular cells: a role of mitochondria and sphingosine-1-phoshate","volume":"16","author":"Ueda","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2020.109526_bb0475","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.2174\/0929867324666170112114525","article-title":"Sphingolipids in genetic and acquired forms of chronic kidney diseases","volume":"24","author":"Ueda","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.cellsig.2020.109526_bb0480","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2215\/CJN.04140510","article-title":"Inflammation, oxidative stress, and insulin resistance in polycystic kidney disease","volume":"6","author":"Menon","year":"2011","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109526_bb0485","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1172\/JCI64401","article-title":"Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease","volume":"123","author":"Zhou","year":"2013","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.cellsig.2020.109526_bb0490","doi-asserted-by":"crossref","first-page":"F1414","DOI":"10.1152\/ajprenal.00426.2015","article-title":"CaMKII as a pathological mediator of ER stress, oxidative stress, and mitochondrial dysfunction in a murine model of nephronophthisis","volume":"310","author":"Bracken","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.cellsig.2020.109526_bb0495","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/978-1-4614-0650-1_8","article-title":"Glycosphingolipids and kidney disease","author":"Mather","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.cellsig.2020.109526_bb0500","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000444926","article-title":"Targeting Glycosphingolipid metabolism to treat kidney disease","volume":"134","author":"Shayman","year":"2016","journal-title":"Nephron"},{"key":"10.1016\/j.cellsig.2020.109526_bb0505","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nm.3092","article-title":"Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy","volume":"19","author":"Rowe","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.cellsig.2020.109526_bb0510","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.cellsig.2020.109526_bb0515","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/ndt\/gfu044","article-title":"Metabolic abnormalities in autosomal dominant polycystic kidney disease","volume":"30","author":"Mao","year":"2015","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cellsig.2020.109526_bb0520","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.ekir.2019.05.140","article-title":"Clinical trial of venglustat, a glucosylceramide synthase (GCS) inhibitor, is supported by preclinical and phase 1 study data","volume":"4","author":"Natoli","year":"2019","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.cellsig.2020.109526_bb0525","first-page":"9","article-title":"Three year open label phase 2a investigation of venglustat safety and exploratory efficacy in classic Fabry patients","volume":"42","author":"Deegan","year":"2019","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.cellsig.2020.109526_bb0530","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ekir.2017.01.003","article-title":"Total kidney volume is a prognostic biomarker of renal function decline and progression to end-stage renal disease in patients with autosomal dominant polycystic kidney disease","volume":"2","author":"Perrone","year":"2017","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.cellsig.2020.109526_bb0535","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1681\/ASN.2019010007","article-title":"GFR slope as a surrogate end point for kidney disease progression in clinical trials: a meta-analysis of treatment effects of randomized controlled trials","volume":"30","author":"Inker","year":"2019","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.cellsig.2020.109526_bb0540","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1681\/ASN.2019010008","article-title":"Evaluating glomerular filtration rate slope as a surrogate end point for ESKD in clinical trials: an individual participant meta-analysis of observational data","volume":"30","author":"Grams","year":"2019","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656820300036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656820300036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T10:55:32Z","timestamp":1760266532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656820300036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":108,"alternative-id":["S0898656820300036"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2020.109526","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycosphingolipid metabolism and polycystic kidney disease","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2020.109526","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109526"}}